Frontier Wealth Management LLC United Therapeutics Corp Transaction History

Frontier Wealth Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$78.31 - $95.34 $207,521 - $252,651	-2,650 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$74.85 - $85.99 $149,700 - $171,980	-2,000 Reduced 43.01%	2,650 $211,000
Q1 2019 May 15, 2019	SELL	$107.15 - $126.84 $1,500 - $1,775	-14 Reduced 0.3%	4,650 $546,000
Q4 2018 Feb 14, 2019	BUY	$101.4 - $128.73 $912 - $1,158	9 Added 0.19%	4,664 $508,000
Q2 2018 Aug 14, 2018	BUY	$101.14 - $118.31 $505 - $591	5 Added 0.11%	4,655 $527,000
Q1 2018 May 15, 2018	BUY	$107.21 - $151.94 $107,210 - $151,940	1,000 Added 27.4%	4,650 $522,000
Q2 2017 Aug 14, 2017	BUY	N/A	3,650	3,650 $474,000

669

42.8M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $17B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Frontier Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Frontier Wealth Management LLC with notifications on news.